A detailed history of Virtu Financial LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 30,012 shares of BCAB stock, worth $41,116. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,012
Holding current value
$41,116
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$1.88 - $3.46 $56,422 - $103,841
30,012 New
30,012 $103,000
Q1 2023

May 01, 2023

BUY
$2.3 - $8.25 $23,694 - $84,991
10,302 New
10,302 $28,000
Q2 2022

Aug 09, 2022

SELL
$2.13 - $5.38 $52,410 - $132,380
-24,606 Reduced 62.72%
14,623 $42,000
Q1 2022

May 17, 2022

BUY
$4.38 - $18.78 $171,823 - $736,720
39,229 New
39,229 $196,000

Others Institutions Holding BCAB

About BioAtla, Inc.


  • Ticker BCAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,304,100
  • Market Cap $49.7M
  • Description
  • BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...
More about BCAB
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.